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Abstract
Increasing data has shown that the cytoskeletal reorganization of podocytes is involved in the 
onset of proteinuria and the progression of glomerular disease. Nephrin behaves as a signal sensor 
of the slit diaphragm to transmit cytoskeletal signals to maintain the unique structure of podocytes. 
However, the nephrin signaling cascade deserves further study. IQGAP1 is a scaffolding protein 
with the ability to regulate cytoskeletal organization. It is hypothesized that IQGAP1 contributes 
to actin reorganization in podocytes through interaction with nephrin. IQGAP1 expression and 
IQGAP1-nephrin colocalization in glomeruli were progressively decreased and then gradually 
recovered in line with the development of foot process fusion and proteinuria in puromycin 
aminonucleoside-injected rats. In cultured human podocytes, puromycin aminonucleoside-induced 
disruption of F-actin and disorders of migration and spreading were aggravated by IQGAP1 
siRNA, and these effects were partially restored by a wild-type IQGAP1 plasmid. Furthermore, 
the cytoskeletal disorganization stimulated by cytochalasin D in COS7 cells was recovered by 
cotransfection with wild-type IQGAP1 and nephrin plasmids but was not recovered either by 
single transfection of the wild-type IQGAP1 plasmid or by cotransfection of mutant IQGAP1 
[Δ1443(S → A)] and wild-type nephrin plasmids. Co-immunoprecipitation analysis using lysates 
of COS7 cells overexpressing nephrin and each derivative-domain molecule of IQGAP1 
demonstrated that the poly-proline binding domain and RasGAP domain in the carboxyl terminus 
of IQGAP1 are the target modules that interact with nephrin. Collectively, these findings showed 
that activated IQGAP1, as an intracellular partner of nephrin, is involved in actin cytoskeleton 
organization and functional regulation of podocytes.
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1. Introduction
Podocytes are terminally differentiated epithelial cells that are essential components of the 
glomerular filtration barrier, and their injury or depletion plays a pivotal role in the onset of 
proteinuria and the progression of glomerular diseases [1–6]. Phenotypic alterations in 
podocytes were detected in a variety of human and experimental glomerular diseases, and 
foot process (FP) fusion is a unique ultrapathological characteristic of podocyte injury [6–8]. 
Therefore, discovery of the molecular mechanism of FP fusion could be a crucial step in 
establishing an effective therapy for podocytopathy.
Previous studies have indicated that cytoskeletal reorganization is the common final 
pathway of FP fusion [9,10]. The highly ordered parallel contractile actin filament bundles 
in FP are transformed into disordered, short, branched ones under pathological conditions. 
Moreover, the elaborate actin cytoskeleton network links the three unique areas of FPs (the 
apical domain, the slit diaphragm [SD] domain and the basal domain) into structurally and 
functionally complete units.
A series of molecules are well known to localize to the SD domain of FPs associated with 
the actin cytoskeleton through scaffold/adaptor proteins, functioning as essential regulators 
of FP structure and dynamics [11]. Nephrin, the first-described SD protein of podocytes, 
behaves as a signaling hub to activate several signaling pathways essential for cytoskeletal 
assembly and cell survival. Collectively, the PI3K-AKT/Rac1, Nck2/N-WASP/Arp2/3, and 
CD2AP/CapZ/F-actin pathways have been reported to be recruited by nephrin to regulate 
cytoskeletal dynamics [12–14].
IQ domain GTPase-activating protein 1 (IQGAP1) is a newly discovered scaffolding protein 
that is also found in the SD region of podocytes [15,16] and contains several functional 
domains that link multiple signaling molecules, including Rac1/Cdc42, Arp2/3, CLIP-170, 
E-cadherin, and EGFR. Following interaction with these proteins, IQGAP1 participates in 
cytoskeletal regulation, ultimately triggering diverse cellular behaviors, such as adhesion, 
migration, and polarization [17].
Our previous study demonstrated that IQGAP1 had a linear distribution along the capillary 
loops of glomeruli in vivo. Furthermore, IQGAP1 and nephrin colocalized in podocytes [18]. 
These findings raised our interest regarding whether IQGAP1 contributes to cytoskeletal 
regulation in podocytes, and whether the function of IQGAP1 in podocytes is realized 
through interaction with nephrin. In the present study, we used a puromycin 
aminonucleoside (PAN) nephrosis rat model and PAN-stimulated human podocytes to 
evaluate the role of IQGAP1 in podocyte cytoskeletal reorganization.
2. Material and methods
2.1. Animals
All experimental procedures were approved by the ethics committee for animal experiments 
of Wuhan University. Twenty-four male SPF Wistar rats (140 to 160 g) were supplied by 
the Hubei Research Center of Experimental Animals and raised in a temperature- and 
humidity-controlled laminar flow room under a 12 h light/12 h dark cycle with free access to 
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tap water and standard rat chow. The PAN model was established [19] by a single 
intraperitoneal injection of PAN (15 mg/100 g body weight, Sigma-Aldrich, USA). The 24-h 
urinary protein was measured on days 0, 4, 7, and 28 after injection. Animals were sacrificed 
under 10% chloral hydrate anesthesia on day 0, 4, 7, or 28. Kidneys were perfused with the 
phosphatase inhibitor vanadate before harvest. Part of the kidney was used for the isolation 
of glomeruli. The cortex of the rest of the kidney was separated and fixed in 4% phosphate-
buffered paraformaldehyde, glutaraldehyde, or tissue-freezing medium for renal 
pathological and immunofluorescence analysis.
Glomeruli were isolated by the differential sieving method [20,21]. The renal cortex was 
separated and successively passed through three stainless steel sieves with pore sizes of 177 
μm (80 mesh), 125 μm (120 mesh), and 74 μm (200 mesh). D-Hank’s buffer containing 
vanadate was used for the continuous rinsing of debris. Glomeruli collected from the last 
sieve were harvested and used for Western blotting analysis.
Transmission electron microscopy was used to evaluate the ultra-structural changes of 
podocytes. Briefly, 2.5% glutaraldehyde-fixed 1-mm3 blocks of renal cortices were 
postfixed with 1% osmic acid, dehydrated in graded ethanol, embedded in EPON, sectioned, 
stained with uranyl acetate and lead citrate, and then observed and recorded with a Hitachi 
H-600 transmission electron microscope (Hitachi, Japan). The mean FP width was defined 
as the total length of the glomerular basement membrane (GBM) divided by the total 
number of FPs. The FP fusion rate was presented as the length of FP fusion divided by the 
total length of the GBM.
2.2. Cell culture
Conditionally immortalized human podocytes were provided by Dr. Moin A. Saleem 
(Academic Renal Unit, Southmead Hospital, Bristol, UK) and cultured in RPMI 1640 
medium (HyClone, USA) containing 10% fetal bovine serum (Gibco, USA), 1× penicillin–
streptomycin, and 1 mM L-glutamine in a 5% CO2 incubator. During the proliferation 
phase, 1× insulin, transferrin, and selenium (ITS) (Invitrogen, USA) was added to the 
medium, and the cells were subcultured at 33 °C. These cells were cultured in a 37 °C 
incubator with ITS-free medium for 7 days to induce differentiation.
COS7 cells were purchased from the Cell Resource Center of Shanghai Institutes for 
Biological Sciences, Chinese Academy of Sciences, and cultured in a 37 °C incubator in 
DMEM (Corning, USA) containing 10% fetal bovine serum (Gibco, USA). G418 (Sigma-
Aldrich, USA) was used to select stably transfected nephrin cell lines (NCOS7). When the 
cells had grown to approximately 60% confluence, 20 μg/mL cytochalasin D (CyD, Enzo 
Life Sciences, Switzerland) was added to the medium for 30 min to depolymerize the actin 
cytoskeleton [22].
2.3. Plasmid construction and transfection
The full-length expression plasmids of nephrin (pcDNA3.1-NPHS1) and IQGAP1 (pCAN-
myc-IQGAP1) were kindly provided by Dr. Lawrence B Holzman (University of Michigan 
Medical School, MI, USA) and Dr. Jon Erickson (Cornell University, NY, USA), 
respectively. The Δ1443(S → A) IQGAP1 mutant plasmid was constructed by mutating the 
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serine to alanine to inhibit IQGAP1 phosphorylation. The pEGFP-C1 eukaryotic expression 
vector was purchased from Clontech (USA) and reformed to carry a Myc tag (pEGFP-C1-
Myc). The Myc primers used in PCR amplification were as follows: sense: 5′-
TCTGAAGAGGATCTGTCCGGACTCAGATCTC-3′ and anti-sense: 5′-
CAGATCCTCTTCAGAGATGAGTTTCTGCTCCTTGTACAGCTCGT CC-3′. The 
calponin homology domain (CHD), the IQGAP-specific repeat motif (IR), the poly-proline 
binding domain (WW), the calmodulin-binding motif (IQ), the RasGTPase-activating 
protein-related domain (GRD), and the RasGAP domain in the carboxyl terminus (RGCT) 
of IQGAP1 were then subcloned into pEGFP-C1-Myc. Detailed information for the 
plasmids is shown in Table 1.
For plasmid transfection, 6 × 105 cells were seeded into a 100-mm dish and incubated with 
transfection complexes containing 5 μg relevant plasmid and 15 μL X-tremeGENE HP DNA 
Transfection Reagent (Roche, Germany) under growth conditions for 72 h.
2.4. Transfection of IQGAP1 siRNA
Transfection of podocytes with IQGAP1 siRNA was performed according to the HiPerFect 
Transfection Reagent Handbook (QIAGEN, Germany). Briefly, 3 × 106 cells were seeded 
into a 100-mm dish and incubated with transfection complexes containing 5 nM IQGAP1 
siRNA (or scrambled siRNA) and 40 μL HiPerFect transfection reagent under growth 
conditions for 48 h.
2.5. Immunofluorescence assay
The frozen kidney sections (5-μm thick) were blocked with 5% BSA for 30 min at 37 °C, 
and cell-climbing films were fixed with 4% paraformaldehyde for 30 min at 4 °C. The 
samples were then incubated with a mixture of nephrin guinea pig primary polyclonal 
antibody (pAb, 1:50; PROGEN Biotechnik, Germany) and IQGAP1 rabbit primary pAb 
(1:50; Santa Cruz, USA) overnight at 4 °C, as well as with a secondary antibody mixture of 
FITC-conjugated goat anti-guinea pig IgG (1:100, Santa Cruz, USA) and TRITC-conjugated 
goat anti-rabbit IgG (1:100, Thermo scientific, USA) at 37 °C for 90 min in darkness. The 
samples were examined using a confocal fluorescence microscope (FV-500, Olympus, 
Japan).
2.6. Real-time PCR
Total RNA was extracted from podocytes using TRIzol reagent (Invitrogen, USA). The 
concentration of collected RNA was measured by spectrophotometry. After the cDNA was 
synthesized, the study was performed with the real-time fluorescent quantitative PCR 
machine (Illumina Eco, USA). The specificity of real-time PCR was detected by melting-
curve analysis. β-actin was used as internal standard. The primers used in this study were as 
follows: IQGAP1, sense: 5′-GGGG AAACGTACCAGAGTGA-3′ and anti-sense: 5′-
TCTCGAGAAAGCTGCACA GA-3′; β-actin, sense: 5′-
CACGATGGAGGGGCCGGACTCATC-3′ and anti-sense: 5′-
TAAAGACCTCTATGCCAACACAGT-3′.
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2.7. Western blotting
The protein concentration was measured using a BCA protein assay (Thermo Scientific, 
USA). Equal amounts of boiled protein in loading buffer were separated using NuPAGE 
10% Bis-Tris SDS-PAGE (Life Technologies, USA) and then electrophoretically transferred 
to polyvinylidene fluoride membranes (Millipore, USA). The membranes were incubated 
with primary antibodies (nephrin rabbit pAb, 1:200, Abcam, UK; p-nephrin rabbit 
monoclonal antibody [mAb], 1:10,000, Abcam, UK; IQGAP1 rabbit pAb, 1:200, Santa 
Cruz, USA; p-serine [p-Ser] mouse mAb, 1:300, Millipore, USA; Myc mouse mAb, 1:2000, 
California Bioscience, USA; β-actin mouse mAb, 1:1000, Santa Cruz, USA) overnight at 4 
°C, followed by incubation with a secondary antibody (LICOR, Lincoln, NE, USA), and the 
membranes were then analyzed using the ODESSEY infrared imaging system (LICOR, 
Lincoln, NE, USA). The integrated optical density for each band was calculated using a Gel-
Pro Analyzer, version 4.5.
2.8. Co-immunoprecipitation
Co-immunoprecipitation experiments were conducted according to the manufacturer’s 
instructions (P2012, Beyotime, China). The total protein of the cultured podocytes or COS7 
cells was extracted using lysis buffer (1.0% Triton X-100, 150 mM NaCl, 5 mM EDTA, 1 
mM PMSF, 20 mM Tris, pH 7.5) that contained a protease inhibitor cocktail (P8340, Sigma-
Aldrich, USA). The samples were centrifuged at 13,000 g for 5 min at 4 °C. Nephrin rabbit 
pAb (2 μg/500 μg total protein; Santa Cruz, USA) or IQGAP1 rabbit pAb (2 μg/500 μg total 
protein, Santa Cruz, USA) was added to the supernatant and rotated overnight at 4 °C. Then, 
the mixture was loaded with protein A + G agarose and incubated for 3 h at 4 °C. The 
centrifuged sediment was saved and mixed with 1× LDS sample buffer. After boiling at 70 
°C for 10 min, the samples were analyzed by Western blotting.
2.9. Staining of the actin cytoskeleton
The cells were fixed with 4% paraformaldehyde at 4 °C for 30 min, washed with ice-cold 
phosphate-buffered saline 3 times for 5 min, and stained with 2.5 μg/mL FITC-phalloidin 
(Sigma-Aldrich, USA) for 1 h at room temperature. Finally, the samples were viewed using 
a confocal fluorescence microscope (FV-500, Olympus, Japan), and the cortical F-actin 
score (CFS) was assessed as previously described [23] to quantify the degree of cytoskeletal 
reorganization.
Concretely, the cytoskeletal reorganization for each cell was scored on a scale ranging from 
0 to 3 based on the degree of cortical F-actin ring formation (score = 0, no cortical F-actin, 
normal stress fibers; score = 1, cortical F-actin deposits below ½ of the cell border; score = 
2, cortical F-actin deposits exceeding ½ of the cell border; score = 3, complete cortical ring 
formation and/or total absence of central stress fibers).
2.10. Cell migration and spreading assays
For the migration assay, 2 wounds per well were made with a sterile pipet tip after the cells 
had grown to complete confluence in a 6-well plate. Pictures were taken just before (0 h) 
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and 6 h after scraping with an inverted phase-contrast microscope. To estimate cell 
migration, the number of cells crossing the 1-mm wound border was calculated.
For the spreading assay, cells (2 × 105) were seeded into a 6-well plate after being digested 
by pancreatin. The morphology of podocytes was observed after 6 h under an inverted 
phase-contrast microscope. Spread cells had extended processes, whereas unspread cells 
were round. The percentage of spreading podocytes was defined as the number of spread 
cells divided by the total number of cells.
2.11. Statistical analysis
The values are presented as the means ± SDs, and the statistical analysis was performed 
using SPSS ver. 17.0. A statistical comparison of the groups was conducted using one-way 
ANOVA, and the LSD test was used for multiple comparisons. P < 0.05 was considered 
statistically significant.
3. Results
3.1. The expression and distribution of IQGAP1 in the glomeruli of rats with PAN nephrosis
We established a rat model of PAN nephrosis to investigate the pathogenesis of FP fusion 
and proteinuria. The PAS staining and proteinuria data (Fig. 1A, B and C) showed that 
protein cast was present in the renal tubular lumen on day 4, and heavier proteinuria was 
found on day 7. However, the proteinuria recovered on day 28 after the injection of PAN. 
Ultrastructure analysis of podocyte (Fig. 1D) indicated that the mean FP width and FP 
fusion rate developed on the same time-course as that of proteinuria.
Next, we performed Western blotting and immunolabeling to detect the expression and 
distribution of IQGAP1 in glomeruli. As shown in Fig. 1E and F, the expression level of 
IQGAP1 was dramatically decreased on days 4 and 7 and then returned to the control level 
on day 28 after PAN injection. Interestingly, the IQGAP1-nephrin colocalization in 
glomeruli were progressively suppressed and gradually recovered in line with the 
development of FP fusion and proteinuria in PAN-injected rats.
3.2. Effect of PAN on the expression of IQGAP1 in vitro
Previous studies have indicated that IQGAP1 is expressed in the SD of podocytes, but its 
exact role in podocytopathy is still elusive. In vitro, we exposed differentiated human 
podocytes to PAN to investigate the possible role of IQGAP1 in podocyte injury. As shown 
in Fig. 2, PAN exposure induced decreased IQGAP1 mRNA and protein expression in a 
dose- and time-dependent manner.
3.3. Effects of PAN on IQGAP1 phosphorylation and the interaction between IQGAP1 and 
nephrin
The colocalization pattern of IQGAP1 and nephrin in the glomeruli of rats with PAN 
nephrosis impelled us to explore the functional role of the interaction between IQGAP1 and 
nephrin in podocytes. As shown in Fig. 3A and B, double immunolabeling and co-
immunoprecipitation analysis indicated that PAN exposure significantly decreased the 
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interaction between IQGAP1 and nephrin in cultured podocytes. Moreover, the serine 
phosphorylation of IQGAP1 was also obviously suppressed by PAN treatment (Fig. 3C).
3.4. Role of IQGAP1 in cytoskeletal regulation
We used IQGAP1 siRNA and plasmids to regulate the endogenous expression of IQGAP1 
in human podocytes to evaluate its role in the signaling pathway of cytoskeletal 
reorganization. After transfecting human podocytes with IQGAP1 siRNA or plasmids, the 
expression of IQGAP1 was examined by Western blotting analysis. As shown in Fig. 4A 
and B, IQGAP1 siRNA significantly decreased IQGAP1 expression whereas the IQGAP1 
plasmid dramatically increased its expression (P < 0.05), indicating the successful 
interference of IQGAP1 expression. However, the expression of nephrin and phosphorylated 
nephrin were not affected in IQGAP1 siRNA- or plasmid-transfected cells.
Interestingly, the alteration of IQGAP1 expression influenced the interaction between 
IQGAP1 and nephrin. The downtrend of IQGAP1 co-immunoprecipitated with nephrin after 
PAN stimulation was aggravated by IQGAP1 siRNA transfection and partially restored by 
wild-type IQGAP1 plasmid transfection (Fig. 4C).
Furthermore, fluorescent analysis of the actin cytoskeleton demonstrated that stress fibers in 
normal cells were disorganized by PAN treatment, and a peripheral actin rim and scattered 
actin fragments were found in PAN-treated cells. Moreover, PAN-induced F-actin 
disruption was aggravated by knocking down endogenous IQGAP1 and partly rescued by 
overexpressing IQGAP1 (Fig. 4D).
3.5. Roles of IQGAP1 in podocyte function
The crucial role of cytoskeletal organization in podocyte function has been widely 
recognized, so we further evaluated the involvement of IQGAP1 in various podocyte 
functions, such as cell migration and spreading. As shown in Fig. 5, PAN stimulation 
apparently provoked podocyte migration but inhibited podocyte spreading (P < 0.05). 
Additionally, IQGAP1 siRNA further significantly enhanced cell migration, whereas 
IQGAP1 overexpression dramatically weakened migration to nearly normal levels. 
Conversely, the PAN-induced inhibition of cell spreading was progressively worsened by 
transfection with IQGAP1 siRNA and partially recovered by transfection with the wild-type 
IQGAP1 plasmid.
3.6. Involvement of the nephrin–IQGAP1 interaction and IQGAP1 phosphorylation in 
cytoskeletal regulation
To investigate the involvement of the nephrin–IQGAP1 interaction and IQGAP1 
phosphorylation in cytoskeletal regulation, we established an NCOS7 cell line with nephrin 
overexpression and then transfected these cells with wild-type and Δ1443(S → A) mutant 
IQGAP1 plasmids, respectively. As shown in Fig. 6A, the transfections were successful. 
Moreover, the stress fibers in COS7 and NCOS7 cells were obviously disrupted by CyD (a 
cytoskeleton depolymerizing agent). Single transfection with either the wild-type or 
Δ1443(S → A) mutant IQGAP1 plasmid did not rescue the stress fibers of the F-actin 
cytoskeleton in CyD–treated COS7 cells. However, in NCOS7 cells, transfection with the 
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wild-type IQGAP1 plasmid dramatically restored CyD-induced cytoskeletal disorganization, 
which was not found in Δ1443(S → A) mutant IQGAP1 plasmid-transfected NCOS7 cells 
(Fig. 6B).
3.7. The WW and RGCT domains of IQGAP1 are the nephrin binding sites
Next, we proceeded to identify the domains of IQGAP1 that are responsible for binding to 
nephrin. Co-immunoprecipitation analysis demonstrated that the WW and RGCT domains 
are necessary for the binding of IQGAP1 to nephrin (Fig. 7).
4. Discussion
Podocyte FP fusion and proteinuria are common symptoms of a series of glomerular 
diseases, such as minimal change nephropathy (MCD) [24], membranous nephropathy [25], 
focal segmental glomerulosclerosis [26], and diabetic nephropathy [27]. FP fusion is the 
characteristic feature of podocyte injury. In the present study, we established a PAN 
nephrosis rat model that mimics the podocyte injury of human MCD [28]. Apart from the 
classical features of urinary protein excretion and FP morphology, concomitant alterations 
of IQGAP1 expression and its colocalization with nephrin were also found in PAN-injected 
rats, suggesting that the nephrin–IQGAP1 signaling cascade might participate in the 
regulation of FP function.
IQGAP1 is the best-studied member of the IQGAP family, which comprises IQGAP1, 
IQGAP2, and IQGAP3. IQGAP1 is evolutionarily conserved and expressed in numerous 
species [29]. As a scaffolding protein, IQGAP1 contains several domains that are essential 
for binding to target proteins: the CHD domain in the N-terminus, followed by the IR 
domain, the WW domain, the IQ domain, the GRD domain, and the RGCT domain. 
Through interactions with numerous membrane proteins, such as E-cadherin, CXCR2, 
EGFR, and NGFR, IQGAP1 transmits extracellular stimuli to the intracellular cytoskeletal 
network [17].
Accumulating evidence has demonstrated that cytoskeletal reorganization is the common 
final pathway of FP fusion. Our results showed that PAN-induced F-actin disruption was 
exacerbated by IQGAP1 downregulation and partially recovered by IQGAP1 upregulation, 
which suggests that IQGAP1 is essential in the regulation of cytoskeletal organization. FP 
fusion is a migratory event of podocytes [30]. IQGAP1 downregulation promoted podocyte 
migration, which was weakened by IQGAP1 overexpression. Meanwhile, IQGAP1 is also 
able to modulate the spreading activity of podocytes. All of the functional experiments 
suggest that IQGAP1 is crucial to maintain the relatively quiescent and digitate spreading 
phenotype of podocytes. Rigothier et al. [16] similarly reported that IQGAP1 is involved in 
podocyte barrier properties through interactions with cytoskeletal proteins in human 
podocytes. However, the role of IQGAP1 in migration in Rigothier’s study contradicts the 
present data. Differences in the stimulating factor and the intensity, as well as complicated 
compensation mechanisms in the IQGAP family, might explain the discrepancy among 
studies.
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Nephrin is an essential SD protein in podocytes that acts as a structural protein to maintain 
the integrity of the glomerular filtration barrier and also as a signaling hub to transmit 
extracellular stimuli into the cytoplasm and to maintain podocyte cell viability and mobility 
[31]. In PAN-stimulated podocytes, actin cytoskeletal remodeling is accompanied by the 
altered colocalization of IQGAP1 and nephrin. Furthermore, the verification test using 
COS7 cells showed that IQGAP1 transfection ameliorated CyD-induced cytoskeletal 
disorganization only with the coexistence of nephrin, suggesting that IQGAP1 exerts its 
cytoskeletal regulatory function through interaction with nephrin. Moreover, a defect of 
IQGAP1 was able to disturb its interaction with nephrin and induce cytoskeletal 
disorganization, indicating that IQGAP1 builds a bridge between the nephrin signaling hub 
and the cytoskeleton network in podocytes.
Additionally, the diverse functions of IQGAP1 are regulated by its phosphorylation [32]. 
This protein is inactive when its two C-terminal domains, GRD and RGCT, associate with 
each other, resulting in intramolecular inhibition. PKC-induced Ser1443 phosphorylation can 
relieve this intramolecular masking and expose the membrane protein and F-actin binding 
sites [33]. Upon mutating the serine (1443) to alanine to inhibit IQGAP1 phosphorylation, 
mutant IQGAP1 plasmid transfection could not alleviate CyD-stimulated cytoskeletal 
disorganization in NCOS7 cells, suggesting that the phosphorylation state of IQGAP1 is 
crucial for its function in cytoskeletal regulation.
A previous study [34] reported that the C-terminal half of the nephrin intracellular domain 
(amino acids 1167–1256) is responsible for IQGAP1 binding. The present research 
consummated the above study and found that the WW and RGCT domains are the specific 
binding sites of IQGAP1 to nephrin. These two domains are crucial for IQGAP1 to bind 
several signaling proteins, such as ERK2, CLIP-170,β-catenin and APC, contributing to the 
diversity of IQGAP1 functions in cellular pathophysiology.
In conclusion, the current study shows, for the first time, that phosphorylated IQGAP1 
interacts with nephrin through its WW and RGCT domains, exerts its regulatory function in 
actin cytoskeleton organization, and ultimately contributes to regulating FP morphology and 
podocyte function (Fig. 8). Therefore, the scaffolding protein IQGAP1 might be a new 
effective therapeutic target for podocytopathy.
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Fig. 1. 
The expression and distribution of IQGAP1 in glomeruli during PAN nephrosis. (A) 
Representative microscopy images of renal pathological changes in various groups (PAS 
staining, original magnification ×200). Scale bar = 20 μm. The black arrows indicate protein 
cast in the renal tubular lumen. (B) Quantitative analysis of urinary protein excretion in 
various groups (n = 6). (C) Coomassie brilliant blue staining of urinary protein in various 
groups. (D) Representative transmission electron microscopy images of glomerular capillary 
walls (original magnification ×10,000) and quantitative analysis of the FP width and FP 
fusion rate (n = 6). Scale bar = 1900 nm. Podo, podocyte. Cap, capillary lumen. (E) Western 
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blotting analysis of glomerular IQGAP1 in various groups (n = 6). (F) Double 
immunolabeling of nephrin and IQGAP1 in glomeruli (original magnification ×400). The 
colocalization area of nephrin and IQGAP1 indicated by the blue dotted line is an enlarged 
view of the boxed region. Scale bar = 20 μm. *p < 0.05 relative to control.
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Fig. 2. 
The expression of IQGAP1 in podocytes stimulated by PAN. (A) (B) Real-time PCR 
analysis of IQGAP1 expression in cultured podocytes stimulated by various concentrations 
of PAN for 6 h or by 50 μg mL−1 PAN for 0–24 h (n = 3). (C) (D) Western blotting analysis 
of IQGAP1 expression in cultured podocytes treated with PAN (n = 3). *p < 0.05, #p < 0.01 
relative to control.
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Fig. 3. 
The interaction between IQGAP1 and nephrin and the phosphorylation of IQGAP1 in PAN-
stimulated podocytes. (A) Double-immunolabeling of nephrin and IQGAP1 in cultured 
podocytes (original magnification ×400). The area indicated by the blue dotted line is the 
region of colocalized nephrin and IQGAP1. Scale bar = 20 μm. (B) Co-immunoprecipitation 
analysis between IQGAP1 and nephrin in podocytes treated with PAN (50 μg mL−1 for 6 h) 
(n = 3). Control IgG is a normal rabbit IgG that replaced the anti-nephrin pAb in the 
precipitation process. (C) The phosphorylation of IQGAP1 detected by co-
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immunoprecipitation (n = 3). Control IgG is a normal rabbit IgG that replaced the anti-
IQGAP1 pAb in the precipitation process. #p < 0.01 relative to control.
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Fig. 4. 
Effects of altered IQGAP1 expression on nephrin, phosphorylated nephrin, cytoskeletal 
reorganization, and the interaction between IQGAP1 and nephrin in podocytes. (A) Western 
blotting analysis of the expression of nephrin, phosphorylated nephrin and IQGAP1 in 
cultured podocytes stimulated by PAN and pre-transfected with IQGAP1 siRNA or 
scrambled siRNA (n = 3). (B) Western blotting analysis of the expression of nephrin, 
phosphorylated nephrin and IQGAP1 in cultured podocytes stimulated by PAN and pre-
transfected with the wild-type IQGAP1 plasmid or null vector (n = 3). (C) Co-
immunoprecipitation analysis between IQGAP1 and nephrin in podocytes transfected with 
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the relevant siRNA or plasmid in the presence or not in the presence of PAN (n = 3). Lysate 
indicates the podocyte lysate and was used as a positive control. Control IgG is a normal 
rabbit IgG and was used as a negative control. (D) FITC-phalloidin staining of the actin 
cytoskeleton in podocytes with altered IQGAP1 expression in the presence or not in the 
presence of PAN (original magnification ×400), and the quantitative analysis of CFS (n = 
100). The nuclei were stained with DAPI. Scale bar = 20 μm. *p < 0.05 relative to control, 
#p < 0.05 relative to PAN-treated cells.
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Fig. 5. 
Involvement of IQGAP1 in podocyte migration and spreading. (A) Representative migration 
results of podocytes stimulated with PAN and pre-transfected with IQGAP1 siRNA or 
plasmids (original magnification ×100). Scale bar = 100 μm. (B) Quantitative analysis of 
podocyte migration. (n = 3). (C) Representative spreading images of podocytes stimulated 
with PAN in the presence of IQGAP1 siRNA or plasmids (original magnification ×400). 
Scale bar = 30 μm. (D) Quantitative analysis of podocyte spreading (n = 3). *p < 0.05 
relative to control, #p < 0.05 relative to PAN-treated cells.
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Fig. 6. 
Involvement of the nephrin–IQGAP1 interaction and IQGAP1 phosphorylation in 
cytoskeletal regulation. (A) Western blotting analysis of the expression of nephrin and 
IQGAP1 in COS7 cells transfected with wild-type IQGAP1, mutated IQGAP1 (ΔSer1443) 
or wild-type nephrin plasmids. The podocyte lysate was used as a positive control. (B) The 
FITC-phalloidin staining of actin cytoskeleton in COS7 (or NCOS7) cells pretreated with 
CyD and transfected with IQGAP1 wild-type or mutated plasmids (original magnification 
×400). Scale bar = 10 μm.
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Fig. 7. 
Identification of the specific domains of IQGAP1 necessary for interacting with nephrin. (A) 
Schematic diagram depicting the domain organization of human IQGAP1 and various 
truncated IQGAP1 mutants. The location indicates the amino acid residues. (B) Detection of 
the nephrin binding sites in IQGAP1. The co-immunoprecipitation study was performed 
using COS7 cell lysates with (+) or without (−) nephrin overexpression and each derivative 
molecule of IQGAP1. Input: total protein extract.
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Fig. 8. 
A schematic model for the involvement of IQGAP1 in actin cytoskeleton organization in 
podocytes.
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Table 1
Detailed IQGAP1 plasmid information.
Plasmids Amino acids Primers
Δ1443(S → A) 1443 Sense: 5′-ATGAAAAAGTCAAAAGCTGTAAAGGAAG-3′
Anti-sense: 5′-CTTTTGACTTTTTCATCTTGTCAGG-3′
CHD 44–159 Sense: 5′-CCGCTCGAGCTCTTTGTCATTTGGAAGAAGC-3′
Anti-sense: 5′-CGGGGTACCTTACAGGTACAAACTGAGTGCATG-3′
IR 266–642 Sense: 5′-CCGCTCGAGCTAAGCAGGACAAAATGACAAATGC-3′
Anti-sense: 5′-CGGGGTACCTTATGTTTTGCCAACATCACCACTTTC-3′
WW 643–744 Sense: 5′-CCGCTCGAGCTCTGAGTGCCCTTCGCTCC-3′
Anti-sense: 5′-CGGGGTACCTTAGGCCAGCCACAGCTGTTC-3′
IQ 745–864 Sense: 5′-CCGCTCGAGCTAATGAAGGCCTGATCACCAGG-3′
Anti-sense: 5′-CGGGGTACCTTAAGGATCCTCAGCATTGATGAGAG-3′
GRD 1004–1237 Sense: 5′-CCGCTCGAGCTTCTGTAATCTTCACACTCTACAAC-3′
Anti-sense: 5′-CGGGGTACCTTAGGAAGCAGCATGCTGAAG-3′
RGCT 1563–1657 Sense: 5′-CCGCTCGAGCTTATACAGCAGCAAGACTACATG-3′
Anti-sense: 5′-CGGGGTACCTTACTTCCCGTAGAACTTTTTGTTGAG-3′
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